Home > News  > Archive

News Archive

Media News Archive

November 2008
Supporting modern standards of corporate governance   more..

Roche signs definitive agreement to acquire Memory Pharmaceuticals   more..

New phase III study of Avastin in advanced breast cancer meets its primary endpoint of increasing the time patients live without their disease getting worse   more..

RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis   more..

Tarceva brings new hope to patients with advanced non-small cell lung cancer   more..

Clinical studies as a logistical challenge   more..
October 2008
Roche posts sustained double-digit sales growth for the first nine months of 2008   more..

Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia   more..

Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer   more..

Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy   more..

Roche invests 215 million Swiss francs in diagnostics facility at Penzberg   more..
September 2008
New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status   more..

Roche to present data showing progress in treating lung, gastric and brain cancers at ESMO   more..
August 2008
Chocos Village Project: contributions from Roche make a difference   more..

Parallel imports of patented drugs: a critical reflexion   more..

Blood Screening Team Wins 'Gold' at Olympic Games   more..

Roche and Meda agree on product transactions   more..

Roche continues to believe its Genentech proposal is fair and generous   more..

Roche Continents: creativity and innovation in Arts and Science   more..
July 2008
FDA Advisory Committee recommends approval of Actemra for the treatment of rheumatoid arthritis   more..

Using a novel sequencing system within RNAi therapeutic research   more..

Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics   more..

Roche acquires Mirus to advance research in the field of RNAi delivery   more..

Roche posts very good results: strong market outperformance - guidance confirmed   more..

Experts in a dialogue on genetics and ethics   more..
June 2008
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment   more..

New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis   more..

Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials   more..

Animal protection plays an important role in innovative research   more..
May 2008
Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer   more..

Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer   more..

Sustainability at Roche - an overview   more..

New Global Roche Position: Pharmaceuticals in the Environment   more..
April 2008
Roche employees support gift charity for Indian children   more..

Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets   more..

Actemra approved in Japan to treat patients with rheumatoid arthritis   more..

Alzheimer, a disease worth researching   more..

Roche fully acquires privately-owned biotech company Piramed   more..
March 2008
Roche says drug for cholesterol does well in tests   more..

New Roche Energy Efficiency Standard Translates Commitment Into Action   more..

Developing a new generation of diagnostics systems   more..

Roche raises dividend by 35 percent   more..
February 2008
Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer   more..

FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer   more..

Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint   more..

CNS Biomarker Day in Basel: bridging the gap between Pharma Research and Pharma Development   more..

Conducting research experiments with great speed   more..
January 2008
Roche helps African, Asian companies make AIDS drug   more..

Successful cooperation: from scientific breakthrough to therapy   more..
December 2007
PCR - test method enriching medical diagnosis   more..
November 2007
Roche arthritis drug effective in late-stage trial   more..
October 2007
Roche Considering Legal Options In Patent Litigation Case   more..

Tarceva approved for lung cancer in Japan   more..

European licence for Roche HIV drug Viracept re-established by European Commission   more..

Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks   more..

Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply   more..
© 2007 Roche Pakistan Limited. Legal Statement - Privacy Policy.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.